Results 141 to 150 of about 10,538,307 (206)

Early kinetics of CA19-9 and CEA after 5-FU-based chemotherapy for gastrointestinal cancers. [PDF]

Discov Oncol
Lange S, Wenzel P, Winter C, Ruland J, Schmid RM, Algül H, Quante M, Friedrich M.   +7 more
europepmc   +1 more source

Tumor Marker Index Based on CEA and CA19-9 as a Prognostic Biomarker in Resectable Colon Cancer. [PDF]

Cancer Diagn Progn
Kosuge T, Mazaki J, Kasahara K, Osakabe H, Kuwabara H, Iwasaki K, Oguma J, Koga H, Kanazawa A, Nagakawa Y.   +9 more
europepmc   +1 more source

腎結石に合併したCA125,CA19-9産生性腎盂乳頭状腺癌の1例(CASE REPORT OF RENAL PELVIC ADENOCARCINOMA ASSOCIATED WITH A RENAL STONE THAT PRODUCED CARBOHYDRATE ANTIGEN 125 AND CARBOHYDRATE ANTIGEN 19-9)

腎結石に合併したCA125,CA19-9産生性腎盂乳頭状腺癌の1例(CASE REPORT OF RENAL PELVIC ADENOCARCINOMA ASSOCIATED WITH A RENAL STONE THAT PRODUCED CARBOHYDRATE ANTIGEN 125 AND CARBOHYDRATE ANTIGEN 19-9)
患者は68歳、男性。腎結石による腎機能低下を伴った症候性高度水腎症のため左腎摘出術が施行された。腎周囲の強度の癒着のため、術中腎盂壁が破れた。病理学的診断は腎盂乳頭状腺癌で、CA125,CA19-9に陽性所見を示した。術前の血液検体を調べたところCA125およびCA19-9が高値であることが明らかとなった。術後化学療法としてパクリタキセルとカルボプラチンを用いたTJ療法が4サイクル施行された。しかし化学療法終了1ヵ月後に局所再発した。腎盂乳頭状腺癌はきわめて稀な疾患であるが、長期にわたる腎結石や腎盂壁の不整を伴った水腎症が認められた場合、腎盂腫瘍の可能性があることを忘れてはならないであろう。CA125およびCA19-9は上部尿路腫瘍の有用なマーカーになり得る。 author text ...
openaire   +1 more source

The 30% reduction of baseline CA19-9 could stratify the prognosis of advanced pancreatic ductal adenocarcinoma with RECIST stable disease after first-line chemotherapy. [PDF]

BMC Cancer
Zhang X, Huang XT, Fu AQ, Huang CS, Xu QC, Lai JM, Liang LJ, Yin XY.   +7 more
europepmc   +1 more source

Clinical Impact of the C-Reactive Protein-Albumin-Lymphocyte Index as a Prognostic Biomarker in Patients With Recurrent Pancreatic Cancer. [PDF]

In Vivo
Sakamoto T, Urakami K, Uehira K, Yoshida J, Kishino M, Morimoto M, Murakami Y, Miyatani K, Shishido Y, Kihara K, Yamamoto M, Matsunaga T, Fujiwara Y.   +12 more
europepmc   +1 more source

Ectopic Pancreatic Adenocarcinoma Arising in the Mesentery of the Jejunum: A Case Report. [PDF]

Surg Case Rep
Furusho I, Hirashita T, Miyoshino W, Takayama H, Kawano Y, Nagasawa Y, Nakamura S, Kawamura M, Masuda T, Endo Y, Daa T, Inomata M.   +11 more
europepmc   +1 more source

Development and validation of prognostic nomograms for intrahepatic cholangiocarcinoma with concomitant hepatolithiasis after radical resection. [PDF]

J Gastrointest Oncol
Li J, Wang XH, Liu Y, Chen W, Mao XH, Yao JH, Xie H, Kan HP.   +7 more
europepmc   +1 more source

Adjuvant FOLFIRINOX versus S-1 monotherapy for resected PDAC: retrospective real-world data. [PDF]

Ther Adv Med Oncol
Tang H, Li Z, You T, Ying J, Cheng Y, Bai C, Wang Y.   +6 more
europepmc   +1 more source

A case of intralobar pulmonary sequestration with high serum CA19-9 levels.

A 38-year-old female presented with cough and fever. A chest X-ray examination revealed an abnormal shadow in the posteroinferior portion of the left hemithorax, and a laboratory examination showed that the serum carbohydrate antigen 19-9 (CA19-9) level ...
Shiota, Yutaro, Furuya, Keizo, Kitade, Masahiro, Ueda, Nobuo   +3 more
core  

Development of a Clinicopathological Prognostic Model and Risk Classification to Predict Disease-Free Survival in Patients with Gastric Adenocarcinoma Following Neoadjuvant Chemotherapy and Curative Gastrectomy. [PDF]

Curr Oncol
Şeyran E, Hafızoğlu E.
europepmc   +1 more source